UnitedHealth Group is mentioned as a healthcare play that has performed well, up 42%.
Source Post
Oscar Health ($OSCR) MLR And Novo Nordisk ($NVO) Overreaction
The creator discusses Oscar Health (OSCR) and Novo Nordisk (NVO). For Oscar Health, the focus is on their upcoming Q2 earnings, with expectations for strong revenue growth and a potential increase in the medical loss ratio. The creator highlights that the stock's valuation is sensitive to margin expansion, suggesting a potential doubling if margins reach 5%. For Novo Nordisk, the stock fell due to an announcement unrelated to earnings, and the creator plans to analyze its impact.
Linked Mentions
Tickers discussed in this post
Adobe has run up recently but is still below all-time highs and could be another winner over the next 12-18 months.
Meta is considered the weakest of the three software picks but is expected to reach over $1000 in the next 5 years.
ServiceNow is highlighted as a potential software winner over the next 12-18 months.
Microsoft is identified as a potential winner in the software space over the next 12-18 months.
Novo Nordisk (NVO) experienced a nearly 10% stock price drop following an announcement unrelated to earnings, prompting an analysis of the news's impact and analyst reactions.
Oscar Health (OSCR) is approaching Q2 earnings with strong revenue growth expected, but the medical loss ratio's impact on margins is key to its valuation, with potential for the stock to double if margins reach 5%.
Linked Signals